Back

Time matters in ATTR-CM: emerging artificial intelligence approaches to screening and clinical considerations for treatment timing - discussion and closing

28 August 2026 (10:40 - 10:45)
Organised by: Logo
Congress Presentation Part of: Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing Cardiac Amyloidosis Open Access ESC Congress 2026 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
Opening address and introduction to ATTR-CM
Associate Professor R. Pfister (Cologne, DE)
Presentation thumbnail
Importance of timely detection of ATTR-CM
Doctor M. Hanna (Cleveland, US)
Presentation thumbnail
Emerging artificial intelligence approaches to ATTR-CM screening
Doctor R. Khera (New Haven, US) Professor C. Lam (Singapore, SG)
Presentation thumbnail
Clinical considerations for ATTR-CM treatment timing with a TTR stabiliser
Doctor P. Soman (Pittsburgh, US) Doctor N. Cyrille-Superville (Charlotte, US)

Access the full session

Session thumbnail
Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing

The Event

Event poster

ESC Congress 2026

28 August 2026 10:40 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources